| P2093 | author name string | Anna García-Altés | |
| P2860 | cites work | Cost-benefit and cost-effectiveness of the incorporation of the pneumococcal 7-valent conjugated vaccine in the routine vaccination schedule of Catalonia (Spain) | Q81497606 |
| | The role of cost-effectiveness in U.S. vaccination policy | Q82093501 |
| | [Efficiency of influenza vaccination in the working population in Spain] | Q83924564 |
| | [A proposed guideline for economic evaluation of health technologies] | Q84976662 |
| | Bias in published cost effectiveness studies: systematic review | Q24541365 |
| | A reappraisal of economic evaluation of pharmaceuticals. Science or marketing? | Q33582633 |
| | Burden of paediatric Rotavirus Gastroenteritis (RVGE) and potential benefits of a universal Rotavirus vaccination programme with a pentavalent vaccine in Spain. | Q33653590 |
| | Burden of disease and economic evaluation of healthcare interventions: are we investigating what really matters? | Q33871595 |
| | Addressing the vaccine confidence gap. | Q34191703 |
| | Conflict of interest in industry-sponsored economic evaluations: real or imagined? | Q34328400 |
| | Twenty years of health care economic analysis in Spain: are we doing well? | Q34464984 |
| | Costing and perspective in published cost-effectiveness analysis | Q34987522 |
| | 30 years of pharmaceutical cost-utility analyses: growth, diversity and methodological improvement | Q35006386 |
| | The value of vaccination: a global perspective | Q35541634 |
| | Health care CBA/CEA: an update on the growth and composition of the literature. | Q36764577 |
| | Do we fully understand the economic value of vaccines? | Q36880575 |
| | Evolution of the health economics of cervical cancer vaccination | Q37320899 |
| | Economic evaluations of massive HPV vaccination: within-study and between study variations in incremental cost per QALY gained. | Q37397788 |
| | Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada | Q37609850 |
| | The future of immunisation policy, implementation, and financing | Q39740370 |
| | Global progress in infectious disease control | Q40849242 |
| | Effectiveness and economic analysis of the whole cell/recombinant B subunit (WC/rbs) inactivated oral cholera vaccine in the prevention of traveller's diarrhoea. | Q42224513 |
| | Social and economic impact of chicken pox vaccine at 15 months of age. Castile and Leon, Spain, 2004 | Q43587695 |
| | Cost-effectiveness analysis of pneumococcal vaccination in Spain | Q44259942 |
| | A cost benefit analysis of routine varicella vaccination in Spain | Q44872126 |
| | Cost-Benefit Analysis of Hepatitis-B Vaccination: A Computerized Decision Model for Spain | Q45044214 |
| | Mathematical modelling of respiratory syncytial virus (RSV): vaccination strategies and budget applications | Q45306780 |
| | Cost effectiveness of hepatitis A virus immunisation in Spain | Q45750359 |
| | Vaccination against hepatitis B virus in Spain: a cost-effectiveness analysis | Q45759566 |
| | Cost-effectiveness of human papillomavirus vaccination and screening in Spain | Q46109665 |
| | A pharmacoeconomic evaluation of seven-valent pneumococcal conjugate vaccine in Spain. | Q47268407 |
| | Estimated economic benefits during the 'decade of vaccines' include treatment savings, gains in labor productivity | Q47981876 |
| | During the 'decade of vaccines,' the lives of 6.4 million children valued at $231 billion could be saved | Q48654474 |
| | Pharmacoeconomic assessment of implementing a universal PCV-13 vaccination programme in the Valencian public health system (Spain). | Q50167719 |
| | Efficiency of the incorporation of the hepatitis A vaccine as a combined A+B vaccine to the hepatitis B vaccination programme of preadolescents in schools. | Q50758077 |
| | Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3-14 years from the provider and societal perspectives. | Q50799286 |
| | Economic benefits for the family of inactivated subunit virosomal influenza vaccination of healthy children aged 3-14 years during the annual health examination in private paediatric offices. | Q51128222 |
| | Relación en España entre la investigación sanitaria financiada por el Sistema Nacional de Salud y la carga de enfermedad en la comunidad | Q57076615 |
| | The improbable plunge. What facts refute reasons to expect that the effectiveness of HPV vaccination programs to prevent cervical cancer could be low? | Q57388789 |
| | De la utilidad de los medicamentos al valor terapéutico añadido y a la relación coste-efectividad incremental | Q57753791 |
| | Health Care CBA and CEA from 1991 to 1996: An Updated Bibliography | Q57991313 |
| | Cost-Benefit Analysis of Haemophilus influenzae Type b Vaccination in Children in Spain | Q59783231 |
| | Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries | Q60624546 |
| | Construcción de un filtro geográfico para la identificación en PubMed de estudios realizados en España | Q62664431 |
| | Cost-effectiveness of pneumococcal vaccination of older people: a study in 5 western European countries | Q74315697 |
| | [Cost-effectiveness of 23-valent antipneumococcical vaccination in Catalonia (Spain)] | Q78352512 |
| | [Analysis of a economic model of a populational influenza immunization strategy in healthy employees] | Q79896293 |
| | Economic evaluation of varicella vaccination in Spain: results from a dynamic model | Q79965616 |
| | [Health promotion: a profitable investment? Economic efficiency of preventive interventions in Spain] | Q80124623 |
| | [Cost-effectiveness of varicella vaccination in Spanish adolescents] | Q80482622 |
| | The cost effectiveness of influenza vaccination for adults aged 50 to 64 years: a model-based analysis for Spain | Q80977637 |
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1656-1665 | |
| P577 | publication date | 2013-01-29 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Systematic review of economic evaluation studies: are vaccination programs efficient in Spain? | |
| P478 | volume | 31 | |